{"entity":{"type":"insider","cik":"0001425381","url":"/insider/0001425381","json_url":"/insider/0001425381.json","name":"Handelsman Karl D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2013-03-27","last":"2014-11-12","span_basis":"filed_date"},"name_variants":[{"name":"Handelsman Karl D.","source":"filing","n_filings":2,"first_seen":"2013-03-27","last_seen":"2014-11-12"}],"transactions":[{"id":6420589,"accession":"0001209191-14-068117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-068117","line_url":"/filing/0001209191-14-068117","is_derivative":false,"issuer_cik":"0001127950","issuer_name":"CODEXIS INC","issuer_ticker":"CDXS","issuer_name_source":null,"issuer_url":"/issuer/0001127950","owner_cik":null,"owner_name":"CMEA Ventures LS Management 2000, L.P.; CMEA Ventures Life Sciences 2000, Civil Law Partnership; Handelsman Karl D.; CMEA VENTURES LIFE SCIENCES 2000 LP; Collier David J","owner_display_name":"CMEA Ventures LS Management 2000, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2921225.0,"shares_display":"2,921,225","price_per_share":2.37,"price_display":"2.37","price_state":"stated","total_value":6923303.25,"total_display":"6,923,303.25","total_whole":"6,923,303","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-10","filed_date":"2014-11-12","scope":"insider","n_lines":2},{"id":4824462,"accession":"0001181431-13-019231","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001181431-13-019231","line_url":"/filing/0001181431-13-019231","is_derivative":false,"issuer_cik":"0001005563","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001005563","owner_cik":null,"owner_name":"CMEA VENTURES VI LP; Sohail Faysal A.; CMEA Ventures VI GmbH & Co. KG; Collier David J; Handelsman Karl D.; BARUCH THOMAS R; Watson James F; CMEA Ventures VI Management, L.P.","owner_display_name":"CMEA VENTURES VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":642857.0,"shares_display":"642,857","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":4499999.0,"total_display":"4,499,999.00","total_whole":"4,499,999","shares_owned_after":2157130.0,"shares_owned_after_display":"2,157,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-25","filed_date":"2013-03-27","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001200375","name":"CODEXIS INC","url":"/issuer/0001200375","role":"Ten percent owner","n_filings":1,"first_seen":"2014-11-12","last_seen":"2014-11-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001373707","name":"TETRAPHASE PHARMACEUTICALS INC","url":"/issuer/0001373707","role":"Ten percent owner","n_filings":1,"first_seen":"2013-03-27","last_seen":"2013-03-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001425381","retrieved_at":"2026-08-22T14:34:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}